A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Psoriasis
Trial Locations (25)

16000

Site Reference ID/Investigator# 38769, Bursa

22030

Site Reference ID/Investigator# 38779, Edirne

27000

Site Reference ID/Investigator# 38782, Gaziantep

31000

Site Reference ID/Investigator# 38778, Hatay

32000

Site Reference ID/Investigator# 38786, Isparta

33000

Site Reference ID/Investigator# 38772, Mersin

34000

Site Reference ID/Investigator# 38765, Istanbul

34093

Site Reference ID/Investigator# 38771, Istanbul

34390

Site Reference ID/Investigator# 38766, Istanbul

34668

Site Reference ID/Investigator# 38770, Istanbul

35000

Site Reference ID/Investigator# 38764, Izmir

41380

Site Reference ID/Investigator# 44104, Kocaeli

42000

Site Reference ID/Investigator# 38781, Konya

44000

Site Reference ID/Investigator# 38773, Malatya

45000

Site Reference ID/Investigator# 38768, Manisa

55139

Site Reference ID/Investigator# 44262, Samsun

58140

Site Reference ID/Investigator# 44103, Sivas

67600

Site Reference ID/Investigator# 44105, Zonguldak

71100

Site Reference ID/Investigator# 44102, Kırıkkale

03000

Site Reference ID/Investigator# 38780, Afyonkarahisar

06000

Site Reference ID/Investigator# 27422, Ankara

Site Reference ID/Investigator# 38776, Ankara

Site Reference ID/Investigator# 38777, Ankara

06100

Site Reference ID/Investigator# 38763, Ankara

09000

Site Reference ID/Investigator# 38767, Aydin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY